Single Ascending Doses of REGN7999, a Monoclonal Antibody Inhibitor of TMPRSS6, Increase Serum Hepcidin and Cause Deep, Sustained Reductions in Serum Iron in Healthy Human Volunteers

海西定 TMPRSS6 铁转运蛋白 医学 转铁蛋白受体 内科学 转铁蛋白饱和度 内分泌学 遗传性血色病 药理学 贫血 血色病 缺铁 生物 转铁蛋白 丝氨酸蛋白酶 生物化学 蛋白酶
作者
Sylvie Rottey,Nikhil Singh,Emily Labriola–Tompkins,Heinrich E. Lob,Kusha Mohammadi,Hazem E. Hassan,Lorna A. Farrelly,Swati Duggal,Harvey Chin,Sarah Hatsell,Michael E. Burczynski,Olivier Harari,Lorah Perlee,Griet Van Lancker
出处
期刊:Blood [Elsevier BV]
卷期号:142 (Supplement 1): 3841-3841
标识
DOI:10.1182/blood-2023-187643
摘要

Background: Iron overload (IOL) develops in dyserythropoieses such as beta-thalassemia and myelodysplastic syndromes due both to red blood cell transfusions as well as inappropriate regulation of the hormone hepcidin, a key regulator of iron homeostasis. Hepcidin, produced in the liver, sequesters iron mainly in enterocytes and macrophages. In the setting of hepcidin down-regulation, toxic levels of labile iron can accumulate in organs such as the heart, liver, bone marrow, pancreas, and pituitary gland. The current standard-of-care for the treatment of IOL is iron chelation. Chelation solubilizes iron for renal excretion, but is associated with toxicities and limited patient satisfaction, severely limiting adoption and efficacy in certain disorders of IOL. There is a high unmet need for novel therapies which can safely reduce, and even prevent, toxic iron accumulation in organs in patients with IOL. Transmembrane serine protease 6 (TMPRSS6) is a membrane-bound serine protease whose expression is highly restricted to hepatocytes, where its only known role is inhibiting hepcidin transcription by cleaving the hemojuvelin co-receptor and thus reducing the bone morphogenetic protein (BMP) signaling pathway driving hepcidin production. Aims: REGN7999, an investigational monoclonal antibody targeting TMPRSS6, is being developed for the treatment of IOL. We have conducted a phase 1, first-in-human, placebo-controlled, single ascending dose study in healthy volunteers (NCT05481333) to explore the safety, tolerability, pharmacokinetics, and pharmacologic effects associated with REGN7999 administration. Methods: Healthy participants at a single center were randomized 6:2 to receive R7999 or placebo in 5 ascending IV and 3 ascending SC cohorts. Key inclusion criteria included hemoglobin, hematocrit, serum iron, and transferrin saturation at or above the lower limit of normal for age and sex. Female participants were required to be non-menstruating. The primary objective of the study was to identify the safety and tolerability of single doses of REGN7999. Key secondary and exploratory objectives included characterizing the drug concentration profile of REGN7999, and evaluating the effects of REGN7999 on serum biomarkers of iron homeostasis. Data reported uses the cutoff date of June 13, 2023. Results: In all cohorts, a total of 64 subjects were exposed. REGN7999 was well-tolerated, with no serious adverse events reported, and no participants developed anemia. Single doses of REGN7999 (ranging from 10 to 900 mg) resulted in acute 2-fold to 12-fold increases in serum hepcidin among all the REGN7999 dose cohorts, as well as acute 50-70% reductions from baseline in serum iron with the longest sustained effects (up to 7 weeks) in the highest IV and SC dose cohorts. Conclusion: Single doses of REGN7999 are well tolerated by healthy volunteers and lead to sustained reductions in serum iron with no associated safety concerns. These findings support continued development of REGN7999 for the treatment of IOL.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
天天快乐应助yuan采纳,获得10
1秒前
2秒前
4秒前
6秒前
wakkkkk完成签到,获得积分10
7秒前
8秒前
GlockieZhao完成签到,获得积分10
9秒前
wanci应助recardo采纳,获得10
9秒前
10秒前
shufessm完成签到,获得积分0
11秒前
赘婿应助默茗采纳,获得10
13秒前
Sw1ft发布了新的文献求助10
13秒前
13秒前
luen完成签到,获得积分10
13秒前
Singularity应助ZLY采纳,获得10
14秒前
16秒前
18秒前
yuan完成签到,获得积分10
19秒前
mbxjsy发布了新的文献求助10
19秒前
19秒前
所所应助秀丽的友卉采纳,获得10
19秒前
recardo发布了新的文献求助10
21秒前
zzx完成签到,获得积分10
21秒前
ZLY完成签到,获得积分10
21秒前
22秒前
yuan发布了新的文献求助10
22秒前
默茗发布了新的文献求助10
25秒前
Jasper应助明理的灭绝采纳,获得10
25秒前
好运滚滚来完成签到 ,获得积分10
26秒前
XLC完成签到,获得积分20
26秒前
一一应助zkx采纳,获得10
28秒前
吃面应助LioXH采纳,获得10
29秒前
29秒前
科研通AI5应助菜鸡5号采纳,获得10
33秒前
34秒前
无名发布了新的文献求助10
34秒前
34秒前
35秒前
炙热乌冬面完成签到 ,获得积分20
39秒前
张宏宇发布了新的文献求助10
40秒前
高分求助中
Mass producing individuality 600
Разработка метода ускоренного контроля качества электрохромных устройств 500
Chinesen in Europa – Europäer in China: Journalisten, Spione, Studenten 500
Arthur Ewert: A Life for the Comintern 500
China's Relations With Japan 1945-83: The Role of Liao Chengzhi // Kurt Werner Radtke 500
Two Years in Peking 1965-1966: Book 1: Living and Teaching in Mao's China // Reginald Hunt 500
A Combined Chronic Toxicity and Carcinogenicity Study of ε-Polylysine in the Rat 400
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3824409
求助须知:如何正确求助?哪些是违规求助? 3366708
关于积分的说明 10442228
捐赠科研通 3086016
什么是DOI,文献DOI怎么找? 1697672
邀请新用户注册赠送积分活动 816458
科研通“疑难数据库(出版商)”最低求助积分说明 769640